Free Trial

Jacobs Levy Equity Management Inc. Lowers Stock Position in Semler Scientific, Inc. (NASDAQ:SMLR)

Semler Scientific logo with Medical background

Jacobs Levy Equity Management Inc. lessened its position in shares of Semler Scientific, Inc. (NASDAQ:SMLR - Free Report) by 57.1% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 41,945 shares of the company's stock after selling 55,792 shares during the quarter. Jacobs Levy Equity Management Inc. owned about 0.45% of Semler Scientific worth $2,265,000 as of its most recent SEC filing.

Several other institutional investors also recently added to or reduced their stakes in SMLR. Global Retirement Partners LLC boosted its holdings in shares of Semler Scientific by 62.5% in the fourth quarter. Global Retirement Partners LLC now owns 1,300 shares of the company's stock valued at $70,000 after acquiring an additional 500 shares during the period. Kovitz Investment Group Partners LLC raised its position in Semler Scientific by 2.2% in the 4th quarter. Kovitz Investment Group Partners LLC now owns 22,885 shares of the company's stock valued at $1,236,000 after purchasing an additional 501 shares during the last quarter. NewEdge Advisors LLC boosted its stake in Semler Scientific by 318.3% during the 4th quarter. NewEdge Advisors LLC now owns 732 shares of the company's stock worth $40,000 after purchasing an additional 557 shares during the period. BNP Paribas Financial Markets purchased a new position in Semler Scientific during the 4th quarter worth $30,000. Finally, Sanctuary Advisors LLC increased its stake in Semler Scientific by 13.2% in the fourth quarter. Sanctuary Advisors LLC now owns 5,012 shares of the company's stock valued at $261,000 after purchasing an additional 584 shares during the period. Institutional investors and hedge funds own 49.37% of the company's stock.

Analysts Set New Price Targets

Separately, Lake Street Capital increased their target price on shares of Semler Scientific from $40.00 to $71.00 and gave the stock a "buy" rating in a research note on Friday, January 24th.

Get Our Latest Research Report on SMLR

Semler Scientific Price Performance

Shares of SMLR stock traded up $5.36 during midday trading on Wednesday, hitting $47.24. The company had a trading volume of 1,008,254 shares, compared to its average volume of 467,917. The stock has a market cap of $526.85 million, a price-to-earnings ratio of 9.50 and a beta of 1.33. The company's 50 day simple moving average is $35.42 and its 200 day simple moving average is $46.98. Semler Scientific, Inc. has a 52-week low of $21.77 and a 52-week high of $81.56.

Semler Scientific (NASDAQ:SMLR - Get Free Report) last issued its quarterly earnings results on Tuesday, May 13th. The company reported ($0.76) earnings per share for the quarter. Semler Scientific had a return on equity of 50.77% and a net margin of 72.65%. The company had revenue of $8.84 million for the quarter.

About Semler Scientific

(Free Report)

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.

Featured Articles

Institutional Ownership by Quarter for Semler Scientific (NASDAQ:SMLR)

Should You Invest $1,000 in Semler Scientific Right Now?

Before you consider Semler Scientific, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Semler Scientific wasn't on the list.

While Semler Scientific currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Defense Stocks Set to Crush the S&P This Summer
Analysts Are Watching These 4 Penny Stocks—You Should Too
Congress Is Pouring Millions Into These 6 Surprising Stocks

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines